Wells Fargo’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
20,495
-1,939
| -9% | -$21.4K | ﹤0.01% | 4319 |
|
|
2025
Q1 | $200K | Buy |
22,434
+730
| +3% | +$6.52K | ﹤0.01% | 4259 |
|
|
2024
Q4 | $204K | Buy |
21,704
+4,695
| +28% | +$44.2K | ﹤0.01% | 4304 |
|
|
2024
Q3 | $137K | Buy |
17,009
+723
| +4% | +$5.83K | ﹤0.01% | 4437 |
|
|
2024
Q2 | $138K | Sell |
16,286
-1,564
| -9% | -$13.3K | ﹤0.01% | 4396 |
|
|
2024
Q1 | $160K | Buy |
17,850
+1,264
| +8% | +$11.3K | ﹤0.01% | 4245 |
|
|
2023
Q4 | $186K | Buy |
16,586
+1,644
| +11% | +$18.5K | ﹤0.01% | 4114 |
|
|
2023
Q3 | $129K | Sell |
14,942
-9,466
| -39% | -$81.7K | ﹤0.01% | 4298 |
|
|
2023
Q2 | $253K | Buy |
24,408
+10,928
| +81% | +$113K | ﹤0.01% | 4201 |
|
|
2023
Q1 | $146K | Buy |
13,480
+12,457
| +1,218% | +$135K | ﹤0.01% | 4334 |
|
|
2022
Q4 | $11.5K | Sell |
1,023
-999
| -49% | -$11.2K | ﹤0.01% | 5172 |
|
|
2022
Q3 | $21K | Sell |
2,022
-585
| -22% | -$6.08K | ﹤0.01% | 5046 |
|
|
2022
Q2 | $24K | Sell |
2,607
-4,835
| -65% | -$44.5K | ﹤0.01% | 5082 |
|
|
2022
Q1 | $71K | Sell |
7,442
-22,662
| -75% | -$216K | ﹤0.01% | 5161 |
|
|
2021
Q4 | $334K | Buy |
30,104
+14,645
| +95% | +$162K | ﹤0.01% | 4637 |
|
|
2021
Q3 | $114K | Sell |
15,459
-173,886
| -92% | -$1.28M | ﹤0.01% | 5043 |
|
|
2021
Q2 | $2.75M | Buy |
189,345
+6,480
| +4% | +$94.1K | ﹤0.01% | 3248 |
|
|
2021
Q1 | $3.73M | Sell |
182,865
-89,297
| -33% | -$1.82M | ﹤0.01% | 2966 |
|
|
2020
Q4 | $4.84M | Sell |
272,162
-4,624
| -2% | -$82.2K | ﹤0.01% | 2764 |
|
|
2020
Q3 | $4.09M | Sell |
276,786
-4,313
| -2% | -$63.8K | ﹤0.01% | 2666 |
|
|
2020
Q2 | $5.9M | Buy |
281,099
+81,190
| +41% | +$1.7M | ﹤0.01% | 2292 |
|
|
2020
Q1 | $4.62M | Buy |
199,909
+3,292
| +2% | +$76.1K | ﹤0.01% | 2263 |
|
|
2019
Q4 | $5.09M | Buy |
196,617
+41,873
| +27% | +$1.08M | ﹤0.01% | 2533 |
|
|
2019
Q3 | $3.01M | Buy |
154,744
+7,981
| +5% | +$155K | ﹤0.01% | 2960 |
|
|
2019
Q2 | $2.4M | Sell |
146,763
-3,558
| -2% | -$58.1K | ﹤0.01% | 3159 |
|
|
2019
Q1 | $3.41M | Buy |
150,321
+18,859
| +14% | +$428K | ﹤0.01% | 2897 |
|
|
2018
Q4 | $3.36M | Buy |
131,462
+2,642
| +2% | +$67.6K | ﹤0.01% | 2795 |
|
|
2018
Q3 | $4.21M | Buy |
128,820
+563
| +0.4% | +$18.4K | ﹤0.01% | 2760 |
|
|
2018
Q2 | $2.91M | Sell |
128,257
-8,305
| -6% | -$188K | ﹤0.01% | 3111 |
|
|
2018
Q1 | $3.31M | Buy |
136,562
+1,148
| +0.8% | +$27.8K | ﹤0.01% | 2922 |
|
|
2017
Q4 | $3.78M | Buy |
135,414
+18,335
| +16% | +$511K | ﹤0.01% | 2814 |
|
|
2017
Q3 | $4.01M | Buy |
117,079
+28,391
| +32% | +$972K | ﹤0.01% | 2693 |
|
|
2017
Q2 | $3.53M | Buy |
88,688
+56,418
| +175% | +$2.25M | ﹤0.01% | 2706 |
|
|
2017
Q1 | $1.19M | Buy |
32,270
+3,100
| +11% | +$114K | ﹤0.01% | 3565 |
|
|
2016
Q4 | $930K | Buy |
29,170
+16,337
| +127% | +$521K | ﹤0.01% | 3686 |
|
|
2016
Q3 | $465K | Buy |
12,833
+502
| +4% | +$18.2K | ﹤0.01% | 3879 |
|
|
2016
Q2 | $280K | Buy |
12,331
+3,199
| +35% | +$72.6K | ﹤0.01% | 4097 |
|
|
2016
Q1 | $172K | Buy |
9,132
+343
| +4% | +$6.46K | ﹤0.01% | 4355 |
|
|
2015
Q4 | $144K | Buy |
8,789
+1,608
| +22% | +$26.3K | ﹤0.01% | 4510 |
|
|
2015
Q3 | $79K | Sell |
7,181
-5,573
| -44% | -$61.3K | ﹤0.01% | 4863 |
|
|
2015
Q2 | $166K | Buy |
12,754
+5,434
| +74% | +$70.7K | ﹤0.01% | 4575 |
|
|
2015
Q1 | $127K | Buy |
7,320
+749
| +11% | +$13K | ﹤0.01% | 4497 |
|
|
2014
Q4 | $97K | Sell |
6,571
-2,415
| -27% | -$35.7K | ﹤0.01% | 4594 |
|
|
2014
Q3 | $207K | Sell |
8,986
-1,128
| -11% | -$26K | ﹤0.01% | 4260 |
|
|
2014
Q2 | $322K | Buy |
+10,114
| New | +$322K | ﹤0.01% | 4067 |
|